文献速递流行病学与生物统计基础与转化研究

宫颈长度对无症状单胎妊娠自发性早产的预后价值:个体参与者数据荟萃分析

Prognostic value of cervical length for spontaneous preterm birth in asymptomatic women with singleton pregnancy: An individual participant data meta-analysis.
PubMed 文献 · PLoS Med · 2026-06-02

该个体参与者数据荟萃分析纳入27项研究共91,404例无症状单胎妊娠孕妇,评估孕中期经阴道超声宫颈长度与自发性早产(SPTB)的关联。宫颈长度与SPTB呈L型非线性关联,长度<40 mm时越短风险越高,≥40 mm时风险稳定。与40 mm相比,20 mm和30 mm者SPTB的比值比分别高6.22倍和2.10倍。

要点

  • 孕中期宫颈长度<40 mm时,自发性早产风险随长度缩短而递增。
  • 宫颈长度20 mm者SPTB风险约为40 mm者的6.22倍。
  • 宫颈长度≥40 mm时自发性早产风险趋于稳定。

核心结论

  • 宫颈长度与自发性早产呈L型非线性关联,长度<40 mm时越短风险越高,≥40 mm时风险稳定。

研究设计与样本

  • 个体参与者数据荟萃分析,纳入27项队列研究或随机对照试验非治疗组,共91,404例无症状单胎妊娠孕妇。
  • 检索Medline、Embase等数据库,检索日期2020年9月30日,更新至2025年11月4日。
  • 采用两阶段逻辑回归模型,宫颈长度作为连续变量,使用限制性立方样条探索非线性关联。

主要发现

  • 平均宫颈长度约20周时为40 mm(标准差9 mm)。
  • SPTB<37周发生4,442例(5.2%)。
  • 与宫颈长度40 mm相比,20 mm和30 mm者SPTB比值比分别高6.22(95%CI 4.76–8.13)和2.10(95%CI 1.85–2.38)倍。

临床怎么用

  • 孕中期经阴道超声测量宫颈长度可用于评估无症状单胎妊娠孕妇的自发性早产风险。
  • 宫颈长度<40 mm时需关注自发性早产风险,长度越短风险越高。

局限性

  • 数据检索率不理想,仅获取全部合格参与者的51%。
  • 所有数据集缺乏全面的SPTB协同预测因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Spontaneous preterm birth (SPTB) is the leading cause of perinatal and early childhood mortality worldwide. Studies have generally suggested that mid-trimester transvaginal sonographic cervical length <25 mm is an important predictor of SPTB. Aggregate data meta-analyses are limited by data availability and reporting in the primary literature. The purpose of this individual participant data meta-analysis (IPDMA) was to quantify the prognostic value of mid-trimester cervical length for SPTB in asymptomatic women with singleton pregnancy, and to assess other factors which may modify this association. METHODS AND FINDINGS: The project was prospectively registered with PROSPERO (CRD42020146987). We searched Medline, Embase, CINAHL, LILACS, Database of Abstracts of Reviews of Effects (DARE), Cochrane database, JBI Database of Systematic Reviews, ClinicalTrials.gov, and Google Scholar. We included cohort studies and non-treatment arms of randomized controlled trials which assessed an association between mid-trimester transvaginal sonographic cervical length and SPTB in asymptomatic women with singleton pregnancy. The search was performed on 30/9/2020, with an update performed on 4/11/2025. The primary outcome was STPB <37 weeks. Two reviewers screened all studies for inclusion and performed risk of bias assessments using QUIPS. We performed a two-stage IPDMA in a logistic regression model using cervical length as a continuous variable (the primary analysis) with restricted cubic splines to explore non-linear associations. IPD of 27 eligible studies were obtained and included (n = 91,404). Mean cervical length was 40 mm (standard deviation [SD] 9 mm) at about 20 weeks' gestation. SPTB <37 weeks occurred in 4,442 (5.2%) participants. An L-shape non-linear association between cervical length and SPTB was observed. A longer cervical length was associated with steeply lower odds of SPTB until it reached 40 mm, beyond which the odds of SPTB became stable. This means that compared to a woman with a cervical length of 40 mm, those with a cervical length of 20 and 30 mm were associated 6.22 and 2.10 higher odds of SPTB (95% confidence intervals [4.76, 8.13] and [1.85, 2.38]), respectively. Limitations included suboptimal data retrieval rate (51% of all eligible participants) and a lack of comprehensive co-predictors of SPTB across all datasets. CONCLUSION: We found a non-linear association between cervical length and SPTB. We found a non-linear association between cervical length and SPTB. Shorter cervix is associated with progressively higher risk of SPTB when length is less than 40 mm, but probability of term birth is high when cervical length is over 40 mm.

来源:PLoS Med,查看原文。版权归原作者所有。

引用

  1. Hughes K, Nguyen D, Aberoumand M, et al. Prognostic value of cervical length for spontaneous preterm birth in asymptomatic women with singleton pregnancy: An individual participant data meta-analysis. PLoS Med. 2026. PMID: 42228679. doi:10.1371/journal.pmed.1004653

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。